دورية أكاديمية

Effects of Flow Rate Modifications on Reported Analgesia and Quality of Life in Chronic Pain Patients Treated with Continuous Intrathecal Drug Therapy.

التفاصيل البيبلوغرافية
العنوان: Effects of Flow Rate Modifications on Reported Analgesia and Quality of Life in Chronic Pain Patients Treated with Continuous Intrathecal Drug Therapy.
المؤلفون: Perruchoud, Christophe, Eldabe, Sam, Durrer, Anne, Bovy, Michèle, Brookes, Morag, Madzinga, Grace, Garner, Fay, Batterham, Alan M., Menoud, Carole, Jacobs, Myriam, Gulve, Ash, Buchser, Eric
المصدر: Pain Medicine; Apr2011, Vol. 12 Issue 4, p571-576, 6p, 3 Charts
مصطلحات موضوعية: CHRONIC pain treatment, QUALITY of life, ACADEMIC medical centers, ANALGESIA, COMBINATION drug therapy, INFUSION therapy, SPINAL infusions, MEDICAL care, PATIENTS, DATA analysis
مستخلص: We compared the analgesia and the quality of life of a constant daily dose of intrathecal drug administered at different flow rates in patients treated for chronic pain. We postulate that the quality of the analgesia, at the same daily dose, will show an infusion rate dependent pattern with decreased pain at higher flow rates. Twenty consecutive patients on stable intrathecal treatment were included in a double-blind three-period crossover study where the same daily dose was administered at single, double, and quadruple flow rates in a randomized sequence. The mean daily pain score and the quality of life (EuroQol measure of health outcome [EQ-5D]) were measured following each flow rate change, after 1 week of stabilization. Visual analog scale (VAS) scores remained unchanged with all flow rates. Compared with the lowest flow rate, the EQ-5D index decreased with double and even more with quadruple flow rate, suggesting a clinically relevant worsening of the health state with higher flow rates. Adverse events were equally distributed in all groups. Pain VAS did not significantly change with flow rate. This is consistent with preclinical data showing very limited increase in drug distribution in the cerebrospinal fluid with much larger flow rate augmentation. However, the quality of life decreased consistently as the flow rate increased. This was entirely due to a worsening of the pain and anxiety dimension of the EQ-5D questionnaire, caused presumably by a slight increase in pain rather than adverse events. We suggest that at higher flow rates increased drug dilution results in a decreased effect at the receptor site. [ABSTRACT FROM AUTHOR]
Copyright of Pain Medicine is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:15262375
DOI:10.1111/j.1526-4637.2011.01088.x